5 Biotech Stocks To Watch As The Industry Continues To Expand
“The biotech industry seems poised to continue its good run on the back of continued advancements in the field of research and subsequent speeding up…
Zenect Wealth
3 Small-Cap Stocks With Big Potential
“While one could argue that small cap stocks are a bit riskier than large, well-funded behemoths, they’re also the place to look for the next…
Will Biotech Buck The Historical Trend This March? (And Where Will Biotech Go After 2021?)
Historically, January and February tend to be very strong months for biotech, while March tends to be very weak. But, with COVID-19 continuing to bear…
Balance Promising Growth And Interest Rate Risk With These 30 Stocks
As the economic recovery continues, Goldman Sachs is advising investors to “balance the appeal of promising businesses with the risk that [interest] rates rise further…
How To Be A Successful Trend Trader – And Supercharge Your Profit Potential This Year
When it comes to the first requirement to be a successful trend trader, the author of today’s article advises “You need to follow the ‘smart…
3 Tech Stocks With The Big Mo
“These are three top stocks for investors with plenty of risk tolerance to consider for aggressive growth portfolios,” says the author of today’s article of…
What’s To Love About Trading Options?
What’s to love about trading options? Quite a bit! From reducing risk, to providing the flexibility to react to market volatility, to achieving consistent returns…
These Recent Insider Purchases Could Be Strong Signals To Potential Investors
When it comes to insider buying, the author of today’s article notes that “Conventional wisdom says that insiders and 10% owners really only buy shares…
Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks
A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –…
With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?
With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in…